Author: Linkermann Andreas Qian Jing Lettau Marcus Kabelitz Dieter Janssen Ottmar
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.9, Iss.1, 2005-02, pp. : 119-134
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Fas Ligand Gene Therapy for Vascular Intimal Hyperplasia
Current Gene Therapy, Vol. 4, Iss. 1, 2004-01 ,pp. :
The Use of Fas Ligand, TRAIL and Bax in Gene Therapy of Prostate Cancer
Current Gene Therapy, Vol. 1, Iss. 1, 2001-05 ,pp. :